KR20080108977A - 항균 활성을 지닌 디카르보닐 화합물 - Google Patents

항균 활성을 지닌 디카르보닐 화합물 Download PDF

Info

Publication number
KR20080108977A
KR20080108977A KR1020087020277A KR20087020277A KR20080108977A KR 20080108977 A KR20080108977 A KR 20080108977A KR 1020087020277 A KR1020087020277 A KR 1020087020277A KR 20087020277 A KR20087020277 A KR 20087020277A KR 20080108977 A KR20080108977 A KR 20080108977A
Authority
KR
South Korea
Prior art keywords
isoxazol
nre
fluoro
phenyl
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087020277A
Other languages
English (en)
Korean (ko)
Inventor
호세 히달고 로드리게이즈
주안 로렌조 카테나 루이즈
이사벨 매십 매십
마리아 델 카르멘 세라 코마스
오스카 레이 푸이그로스
카르멘 라구나스 아르날
카롤리나 살세도 로카
돌로스 발사 로페즈
Original Assignee
라보라토리오스 살바트, 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라보라토리오스 살바트, 에스.에이. filed Critical 라보라토리오스 살바트, 에스.에이.
Publication of KR20080108977A publication Critical patent/KR20080108977A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1020087020277A 2006-01-19 2007-01-18 항균 활성을 지닌 디카르보닐 화합물 Withdrawn KR20080108977A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200600158 2006-01-19
ES200600158 2006-01-19

Publications (1)

Publication Number Publication Date
KR20080108977A true KR20080108977A (ko) 2008-12-16

Family

ID=37781676

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087020277A Withdrawn KR20080108977A (ko) 2006-01-19 2007-01-18 항균 활성을 지닌 디카르보닐 화합물

Country Status (9)

Country Link
US (1) US20100075984A1 (cg-RX-API-DMAC7.html)
EP (1) EP1976837A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009523764A (cg-RX-API-DMAC7.html)
KR (1) KR20080108977A (cg-RX-API-DMAC7.html)
CN (1) CN101405277A (cg-RX-API-DMAC7.html)
AU (1) AU2007206889A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0706938A2 (cg-RX-API-DMAC7.html)
CA (1) CA2637052A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007082910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5291292B2 (ja) * 2007-02-01 2013-09-18 協同油脂株式会社 金属加工用油剤及び金属加工方法
CA2743971A1 (en) 2008-11-20 2010-05-27 Panacea Biotec Ltd. Novel antimicrobials
MX2012000231A (es) 2009-06-26 2012-03-07 Panacea Biotec Ltd Nuevos aza-biciclo-hexanos.
WO2011002067A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 複素環化合物およびその用途
CN109503569B (zh) * 2019-01-03 2021-01-15 山东大学 噻唑类衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
WO2004014392A1 (en) * 2002-07-29 2004-02-19 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2005082892A2 (en) * 2004-02-17 2005-09-09 Dr. Reddy's Laboratories Ltd. Triazole compounds as antibacterial agents and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
BRPI0706938A2 (pt) 2011-04-12
JP2009523764A (ja) 2009-06-25
US20100075984A1 (en) 2010-03-25
WO2007082910A1 (en) 2007-07-26
CA2637052A1 (en) 2007-07-26
AU2007206889A1 (en) 2007-07-26
CN101405277A (zh) 2009-04-08
EP1976837A1 (en) 2008-10-08

Similar Documents

Publication Publication Date Title
KR101804588B1 (ko) 조혈 성장 인자 모방체 소분자 화합물 및 이의 용도
AU2005292152B2 (en) Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors
KR101877187B1 (ko) 치환된 다이하이드로이소퀴놀린온 화합물
JP7175888B2 (ja) 選択的hdac1、2阻害剤としてのピペラジン誘導体
CN101711243B (zh) 3-氨基-6-(1-氨基-乙基)-四氢吡喃衍生物
WO2001030757A1 (en) Drug discharge pump inhibitors
JP5957537B2 (ja) 複素環式ウレア化合物
KR20030040552A (ko) 질소 함유 방향환 유도체
JPWO2010061971A1 (ja) ピリジン−3−カルボキシアミド誘導体
CA2942817A1 (en) Trka kinase inhibitors, compositions and methods thereof
EP1878730A1 (en) Substituted isoxazolines, pharmaceutical compositions containing the same, methods of preparing the same, and uses of the same
AU2017200985A1 (en) Benzamides
KR20080108977A (ko) 항균 활성을 지닌 디카르보닐 화합물
JP2022549471A (ja) Ep300/cbp阻害剤
JP2004518724A (ja) ピリドアリールフェニル・オキサゾリジノン抗菌剤、および関連の組成物および方法
CN104981469B (zh) 抗微生物剂
AU2007297627A1 (en) Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of Alzheimer's disease
CN101374831B (zh) 四氢吡喃抗生素
JP7678595B2 (ja) ピロロ[2,3‐b]ピリジン‐3‐カルボキサミド組成物及び聴力損失を改善するための方法
EP1912662B1 (en) Peptide deformylase inhibitors
RU2802283C2 (ru) Новый ингибитор на основе производного хинолина
WO2022096990A1 (en) Novel hetrocyclic compounds
HK40078094B (zh) 作为trpv4拮抗剂的嘧啶-4(3h)-酮衍生物
CN109942579A (zh) β-内酰胺酶抑制剂含脲双环化合物及其制备方法和应用
WO2007067904A2 (en) Peptide deformylase inhibitors

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080819

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid